Published in Can Fam Physician on July 01, 2014
Not antagonist treatment. Can Fam Physician (2014) 1.07
Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Can Fam Physician (2015) 0.78
Response. Can Fam Physician (2014) 0.75
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am (1998) 2.33
ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol (2012) 1.71
The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol (2007) 1.54
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs (2012) 1.30
Opioid detoxification in pregnancy. Obstet Gynecol (1998) 1.28
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Drug Alcohol Depend (2012) 1.20
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10
SOGC clinical practice guidelines: Substance use in pregnancy: no. 256, April 2011. Int J Gynaecol Obstet (2011) 1.09
Congenital malformations of the central nervous system produced by narcotic analgesics in the hamster. Am J Obstet Gynecol (1975) 0.91
The interference of naloxone hydrochloride in the teratogenic activity of opiates. Teratology (1985) 0.89
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43
Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42
Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42
Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42
Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41
Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40
Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40
Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39
Electric shock during pregnancy. Can Fam Physician (2003) 1.39
Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39
"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39
Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35
Modulation of celecoxib pharmacokinetics by food in pediatric patients. Clin Pharmacol Ther (2005) 1.33
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol (2005) 1.29
Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28
The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med (2007) 1.26
Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ (2008) 1.26
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol (2002) 1.25
Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics (2004) 1.25
Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics (2008) 1.24
Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol (2010) 1.23
Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf (2004) 1.21
Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicol Teratol (2003) 1.21
Folate fortification and supplementation--are we there yet? Reprod Toxicol (2008) 1.21
Guidelines for maternal codeine use during breastfeeding. Can Fam Physician (2009) 1.21
Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits. J Physiol (2011) 1.21
Hair cortisol as a potential biologic marker of chronic stress in hospitalized neonates. Neonatology (2007) 1.20
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol (2005) 1.20
Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol (2005) 1.19
The effect of a short tutorial on the incidence of prescribing errors in pediatric emergency care. Can J Clin Pharmacol (2006) 1.18
Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother (2002) 1.18
Depression during Pregnancy : Overview of Clinical Factors. Clin Drug Investig (2004) 1.18
The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica (2007) 1.18
Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev (2008) 1.18
Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. Am J Obstet Gynecol (2002) 1.17
Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother (2003) 1.17